This content is machine translated Kidney cancer Palliative systemic therapy for metastatic renal cell carcinoma Renal cell carcinoma (RCC) is the most common malignant disease of the kidney. There are currently no established predictive biomarkers to guide palliative therapy with checkpoint inhibitors (CPI), tyrosine kinase… CME-Test
View Post 14 min This content is machine translated Kidney cancer Palliative systemic therapy for metastatic renal cell carcinoma Renal cell carcinoma (RCC) is the most common malignant disease of the kidney. There are currently no established predictive biomarkers to guide palliative therapy with checkpoint inhibitors (CPI), tyrosine kinase… CME-Test
View Post 4 min This content is machine translated Immuno-Oncology New pathways for improved cancer treatment? Long-term survival of patients with advanced-stage carcinoma is still an area where research is far from successful. In the field of melanoma, the approval of ipilimumab in 2011 has made…
View Post 4 min This content is machine translated Lung, kidney cancer and chronic myeloid leukemia What does modern clinical practice look like? At the DGHO Congress in Vienna, various aspects in clinical practice in non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and chronic myeloid leukemia were addressed. In particular, the…
